CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kakkanaiah, V. N.
Right arrow Articles by Peter, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kakkanaiah, V. N.
Right arrow Articles by Peter, J. B.

Clinical and Diagnostic Laboratory Immunology, July 1998, p. 499-502, Vol. 5, No. 4
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Concentrations of Circulating beta -Chemokines Do Not Correlate with Viral Load in Human Immunodeficiency Virus-Infected Individuals

Vellalore N. Kakkanaiah, Emmanuel A. Ojo-Amaize, and James B. Peter

Specialty Laboratories, Santa Monica, California 90404-3900

Received 5 February 1998/Returned for modification 20 March 1998/Accepted 11 May 1998

The CC or beta -chemokines MIP-1alpha , MIP-1beta , and RANTES are the primary components of human immunodeficiency virus type 1 (HIV-1)-suppressive soluble factors in vitro. We studied the relationship between the concentrations of MIP-1alpha , MIP-1beta , and RANTES in plasma and HIV viral load in HIV-infected subjects. The HIV-positive patient group (n = 140) had significantly lower concentrations of all three beta -chemokines (MIP-1alpha , P < 0.0005; MIP-1beta , P < 0.005; RANTES, P < 0.0005) than the control group (n = 58 for MIP-1alpha , n = 27 for MIP-1beta , and n = 59 for RANTES). In addition, we divided the patient group into three subgroups (high, moderate, and low) based on the number of HIV-1 RNA copies in the plasma (as measured by quantitative HIV RNA PCR). Again, all three subgroups had significantly lower concentrations of the beta -chemokines than the HIV-negative control group. However, there was no significant difference in plasma beta -chemokine concentrations among the three subgroups within the patient group (P < 0.3). Although our results demonstrate that HIV-infected individuals had significantly lower concentrations of circulating beta -chemokines than healthy uninfected control subjects, we found no correlation between the concentrations of beta -chemokines in plasma and HIV-1 viral load in HIV-infected individuals.

Clinical and Diagnostic Laboratory Immunology, July 1998, p. 499-502, Vol. 5, No. 4
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 1998 by the American Society for Microbiology. All rights reserved.